U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H13N.ClH
Molecular Weight 195.689
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PARGYLINE HYDROCHLORIDE

SMILES

Cl.CN(CC#C)CC1=CC=CC=C1

InChI

InChIKey=BCXCABRDBBWWGY-UHFFFAOYSA-N
InChI=1S/C11H13N.ClH/c1-3-9-12(2)10-11-7-5-4-6-8-11;/h1,4-8H,9-10H2,2H3;1H

HIDE SMILES / InChI

Molecular Formula C11H13N
Molecular Weight 159.2276
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Pargyline is an irreversible selective monoamine oxidase (MAO)-B inhibitor, which possesses higher selectivity to this isoform in comparison with MAO-A. It was approved under brand name eutonyl for the treatment hypertension, but then this drug was discontinued.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Eutonyl

Approved Use

Unknown
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
75 ng/mL
50 mg single, oral
dose: 50 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
PARGYLINE plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
272 ng × h/mL
50 mg single, oral
dose: 50 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
PARGYLINE plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
5 h
50 mg single, oral
dose: 50 mg
route of administration: Oral
experiment type: SINGLE
co-administered:
PARGYLINE plasma
Homo sapiens
population: UNHEALTHY
age: ADULT
sex: UNKNOWN
food status: UNKNOWN
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer





Drug as perpetrator​

Drug as perpetrator​

TargetModalityActivityMetaboliteClinical evidence
yes
yes
yes
Drug as victim

Drug as victim

TargetModalityActivityMetaboliteClinical evidence
yes
yes
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Role of the sympathetic nervous system in daunomycin-induced arrhythmia in the monkey.
1970 Jul
Testosterone-attenuated stereotype and hyperactivity induced by beta-phenylethylamine in pargyline-pretreated rats.
1978 Aug
Determination of the role of serotonergic and cholinergic systems in apomorphine--induced aggressiveness in rats.
1979 Mar-Apr
Selective and nonselective monoamine oxidase inhibitors: behavioral disturbances during their administration to depressed patients.
1982 May
The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
1982 Nov 15
Pargyline-induced mania in primary affective disorder: case report.
1983 Jan
Treatment with clorgyline and pargyline differentially decreases clonidine-induced hypotension and bradycardia.
1984 Sep
[Effects of pentoxifylline on 5-hydroxytryptamine in the mouse brain].
1985 Nov
Chronic but not acute treatment with antidepressants enhances the electroconvulsive seizure response in rats.
1985 Oct
Pargyline reduces/prevents neuroleptic-induced acute dystonia in monkeys.
1987
Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat.
1987 Sep
The involvement of noradrenaline, 5-hydroxytryptamine and acetylcholine in imipramine-induced seizures in mice.
1993 Oct 15
The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine.
1994 Jul 11
GABAergic and dopaminergic systems may be involved in seizures induced by pyrimethamine in mice.
1994 Oct
Clinical review: immunomodulatory effects of dopamine in general inflammation.
2004 Dec
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
2004 May 25
IRAK-M regulates chromatin remodeling in lung macrophages during experimental sepsis.
2010 Jun 16
Oxidative stress by monoamine oxidases is causally involved in myofiber damage in muscular dystrophy.
2010 Nov 1
Alterations in hippocampal serotonergic and INSR function in streptozotocin induced diabetic rats exposed to stress: neuroprotective role of pyridoxine and Aegle marmelose.
2010 Sep 25
Acute effects of resveratrol to enhance cocaine-induced dopamine neurotransmission in the striatum.
2013 May 10
Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
2015 Mar 25
Patents

Sample Use Guides

Unknown
Route of Administration: Oral
In Vitro Use Guide
Curator's Comment: The two molecular forms of monoamine oxidase (MAO), MAO-A and MAO-B, were determined quantitatively in discrete regions of the human brain at autopsy, and in cerebral microvessels, choroid plexus and liver samples from the same subjects. MAO was assessed by specific[3H] pargyline binding, which is stoichiometric and irreversible, and by measuring the rate of oxidation of several MAO substrates. Basal ganglia structures (caudate, putamen, globus pallidus and substantia nigra) and hippocampus had about twice the levels of MAO that were present in the cerebral cortex and cerebellum. Cerebral microvessels, which constitute the blood-brain barrier, had minimal MAO, while the choroid plexus, which constitutes the blood-cerebrospinal fluid barrier, and the liver had higher MAO levels than any brain region. The vast majority of MAO (80-95%) in these tissues was of the B type, except in microvessels, where total MAO activity was low. Specific [3H]pargyline binding correlated well with the oxidation rates for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and benzylamine in all tissues. Both specific [3H]pargyline binding and the rate of oxidation of MAO substrates increased with age.
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:11:58 GMT 2023
Edited
by admin
on Fri Dec 15 16:11:58 GMT 2023
Record UNII
W70V6I2OMY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PARGYLINE HYDROCHLORIDE
MART.   MI   ORANGE BOOK   USAN   USP-RS   VANDF   WHO-DD  
USAN  
Official Name English
EUTONYL
Brand Name English
N-Methyl-N-2-propynylbenzylamine hydrochloride
Systematic Name English
PARGYLINE HYDROCHLORIDE COMPONENT OF EUTRON
Common Name English
BENZENEMETHANAMINE, N-METHYL-N-2-PROPYNYL-, HYDROCHLORIDE
Systematic Name English
PARGYLINE HCL
Common Name English
NSC-43798
Code English
PARGYLINE HYDROCHLORIDE [VANDF]
Common Name English
PARGYLINE HYDROCHLORIDE [ORANGE BOOK]
Common Name English
A-19120
Code English
PARGYLINE HYDROCHLORIDE [MI]
Common Name English
PARGYLINE HYDROCHLORIDE [MART.]
Common Name English
Pargyline hydrochloride [WHO-DD]
Common Name English
EUTRON COMPONENT PARGYLINE HYDROCHLORIDE
Common Name English
PARGYLINE HYDROCHLORIDE [USAN]
Common Name English
MO-911
Code English
Classification Tree Code System Code
NCI_THESAURUS C667
Created by admin on Fri Dec 15 16:11:58 GMT 2023 , Edited by admin on Fri Dec 15 16:11:58 GMT 2023
NCI_THESAURUS C270
Created by admin on Fri Dec 15 16:11:58 GMT 2023 , Edited by admin on Fri Dec 15 16:11:58 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID1044647
Created by admin on Fri Dec 15 16:11:58 GMT 2023 , Edited by admin on Fri Dec 15 16:11:58 GMT 2023
PRIMARY
ECHA (EC/EINECS)
206-175-1
Created by admin on Fri Dec 15 16:11:58 GMT 2023 , Edited by admin on Fri Dec 15 16:11:58 GMT 2023
PRIMARY
MERCK INDEX
m8412
Created by admin on Fri Dec 15 16:11:58 GMT 2023 , Edited by admin on Fri Dec 15 16:11:58 GMT 2023
PRIMARY Merck Index
RXCUI
82069
Created by admin on Fri Dec 15 16:11:58 GMT 2023 , Edited by admin on Fri Dec 15 16:11:58 GMT 2023
PRIMARY RxNorm
DRUG BANK
DBSALT000304
Created by admin on Fri Dec 15 16:11:58 GMT 2023 , Edited by admin on Fri Dec 15 16:11:58 GMT 2023
PRIMARY
SMS_ID
100000085538
Created by admin on Fri Dec 15 16:11:58 GMT 2023 , Edited by admin on Fri Dec 15 16:11:58 GMT 2023
PRIMARY
ChEMBL
CHEMBL673
Created by admin on Fri Dec 15 16:11:58 GMT 2023 , Edited by admin on Fri Dec 15 16:11:58 GMT 2023
PRIMARY
PUBCHEM
9373
Created by admin on Fri Dec 15 16:11:58 GMT 2023 , Edited by admin on Fri Dec 15 16:11:58 GMT 2023
PRIMARY
EVMPD
SUB03653MIG
Created by admin on Fri Dec 15 16:11:58 GMT 2023 , Edited by admin on Fri Dec 15 16:11:58 GMT 2023
PRIMARY
NSC
43798
Created by admin on Fri Dec 15 16:11:58 GMT 2023 , Edited by admin on Fri Dec 15 16:11:58 GMT 2023
PRIMARY
NCI_THESAURUS
C66323
Created by admin on Fri Dec 15 16:11:58 GMT 2023 , Edited by admin on Fri Dec 15 16:11:58 GMT 2023
PRIMARY
FDA UNII
W70V6I2OMY
Created by admin on Fri Dec 15 16:11:58 GMT 2023 , Edited by admin on Fri Dec 15 16:11:58 GMT 2023
PRIMARY
CAS
306-07-0
Created by admin on Fri Dec 15 16:11:58 GMT 2023 , Edited by admin on Fri Dec 15 16:11:58 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY